Director/PDMR Shareholding

RNS Number : 1140Q

GlaxoSmithKline PLC

09 October 2013

 



 Notification of Transactions of Directors, Persons Discharging

Managerial Responsibility or Connected Persons

The Administrators of the GlaxoSmithKline 2009 Performance Share Plan notified the Company and the under-mentioned persons on 8 October 2013 of the following increases in their notional interests in Ordinary Shares at a price of 1571 pence per Ordinary Share and American Depositary Shares (ADSs) at a price of $50.84 per ADS following the notional re-investment of the dividend paid to shareholders on 3 October 2013.

	Ordinary Shares	ADSs
Sir Andrew Witty	17,855.571
Dr M M Slaoui		5,353.520
Mr S Dingemans	6,924.754
Mr S M Bicknell	1,873.095
Mr R G Connor	1,241.889
Mrs D P Connelly		2,258.480
Mr S A Hussain	5,449.411
Mr W C Louv		1,559.989
Mr D S Redfern	2,675.845
Ms C Thomas	3,719.017
Mr P C Thomson	1,180.887
Mr D E Troy		3,008.734
Dr P J T Vallance	6,159.639
Ms E Walmsley	3,497.511
Mr C Weber	872.878
Mrs V A Whyte	438.511

The notional dividends accrued will be paid out in proportion to the percentage of participants' Performance Share Plan holdings that vest following the end of the relevant measurement period.

This notification relates to transactions notified in accordance with Disclosure and Transparency Rule 3.1.4R(1)(a).

S M Bicknell

Company Secretary

9 October 2013

 

END

 

 

RDSFKLFBXBFBFBL